Manufacturer record
Bajaj Formulations: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
14 batches manufactured by Bajaj Formulations (Uttarakhand) were declared Not of Standard Quality between December 2021 and September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: T25H531B, Ofloxacin Tablets IP 200 mg (exp Jul 2027). DTL, Delhi (state lab) found it not of standard quality: TESTS FOR UNIFORMITY OF WEIGHT. Listed in the September 2026 alert.
Records by type
14 records linked to Bajaj Formulations in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Ofloxacin Tablets IP 200 mg | Batch T25H531BMfg Aug 2025 · Exp Jul 2027 | TESTS FOR UNIFORMITY OF WEIGHTUniformity of weight/content | DTL, DelhiState lab | Sep 2026 |
| Nicorandil Tablets IP 5mg | Batch T26A675AMfg Jan 2026 · Exp Dec 2027 | The sample is not of standard quality in respect of Assay.Assay | LUCKNOW, Uttar PradeshState lab | Sep 2026 |
| Aceclofenac and Paracetamol Tablets | Batch T24K557CMfg Nov 2024 · Exp Oct 2026 | TESTS FOR UNIFORMITY OF WEIGHT.Uniformity of weight/content | DTL, DelhiState lab | Sep 2026 |
| Diclofenac Potassium, & Serratiopeptidase Tablets | Batch T25K035BMfg Nov 2025 · Exp Oct 2027 | The sample is not of Standard Quality with respect to DisintegrationDisintegration | LUCKNOW LABState lab | Aug 2026 |
| Aceclofenac and Parcetamol IP) | Batch T251733CMfg Sep 2025 · Exp Aug 2027 | 01. ASSAY OF ACECLOFENAC I.P. ?Less than prescribed limit.Assay | SFDTL UttarakhandState lab | Jul 2026 |
| Diabit-GM | Batch T25F640AMfg Jun 2025 · Exp May 2027 | The sample fails in the Test for DescriptionDescription | MDTL KathuaState lab | Apr 2026 |
| Metformin Hydrochloride (SR) & Glimepride Tablets IP (Yathoglim-M3) | Batch T25C554AMfg Mar 2025 · Exp Feb 2027 | Sample fail the test Assay of Glimepiride.Assay | RDTL, Ernakulam, KeralaState lab | Oct 2025 |
| Intraconazole Capsules 100 mg (ITRASEC-100) | Batch C24I028DMfg Sep 2024 · Exp Aug 2026 | The sample does not conform to I.P. Addendum 2024 with respect to the Dissolution of Itraconazole.Dissolution | CDL, KolkataCDSCO lab | Oct 2025 |
| Pantoprazole 40mg | Batch T24E999AMfg May 2024 · Exp Apr 2026 | DissolutionDissolution | DTL,Dalgate Srinagar Kashmir(J&K)State lab | Aug 2025 |
| Kresertan - 40 | Batch T24E178AMfg May 2024 · Exp Apr 2026 | Failing in Disintegration Test.Disintegration | Drug Testing Laboratory Dalgate, SrinagarState lab | Jul 2025 |
| Racecadotril & Oflozacin Suspension (Combact-O + Suspension) | Batch L23J003AMfg Oct 2023 · Exp Sep 2025 | Assay of Racecadotril & OfloxacinAssay | CDTL MumbaiCDSCO lab | Oct 2024 |
| Levocetrizine Dihydrochloride & Montelukast Sodium Tablets I.P. Zeemont | Batch T22H370CMfg Aug 2022 · Exp Jul 2024 | THE SAMPLE DOES NOT COMPLY WITH IP REQUIREMENTS FOR DISSOLUTION TEST FOR MONTELUKAST.Dissolution | State Lab MaharashtraState lab | Jun 2024 |
| Levetiracetam Tablets U.S.P.500 Mg (LEVEEG-500) | Batch T23D050AMfg Apr 2023 · Exp Mar 2025 | THE SAMPLE DOES NOT COMPLY WITH USP REQUIREMENTS FOR DISSOLUTION.Dissolution | State Lab MaharashtraState lab | Jun 2024 |
| Acebrophylline (SR), Fexofenadine Hydrochloride and Montelukast Sodium Tablets (LEVOICE-3D TABLETS) | Batch T21G522DMfg Jul 2021 · Exp Jun 2023 | Assay of Montelukast Sodium calculated as MontelukastAssay | RDTL ChandigarhState lab | Dec 2021 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.